NO865028L - Fremgangsmaate for fremstilling av et terapeutisk system. - Google Patents

Fremgangsmaate for fremstilling av et terapeutisk system.

Info

Publication number
NO865028L
NO865028L NO865028A NO865028A NO865028L NO 865028 L NO865028 L NO 865028L NO 865028 A NO865028 A NO 865028A NO 865028 A NO865028 A NO 865028A NO 865028 L NO865028 L NO 865028L
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutic system
therapeutic
Prior art date
Application number
NO865028A
Other languages
English (en)
Norwegian (no)
Other versions
NO865028D0 (no
Inventor
Victor Brantl
Volkmar Haeselbarth
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO865028D0 publication Critical patent/NO865028D0/no
Publication of NO865028L publication Critical patent/NO865028L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO865028A 1985-12-14 1986-12-12 Fremgangsmaate for fremstilling av et terapeutisk system. NO865028L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3544311 1985-12-14

Publications (2)

Publication Number Publication Date
NO865028D0 NO865028D0 (no) 1986-12-12
NO865028L true NO865028L (no) 1987-06-15

Family

ID=6288476

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865028A NO865028L (no) 1985-12-14 1986-12-12 Fremgangsmaate for fremstilling av et terapeutisk system.

Country Status (13)

Country Link
US (1) US4826686A (fr)
EP (1) EP0227988A3 (fr)
JP (1) JPS62148422A (fr)
KR (1) KR870006054A (fr)
AU (1) AU593863B2 (fr)
CA (1) CA1291039C (fr)
DK (1) DK599986A (fr)
FI (1) FI865069A (fr)
IL (1) IL80950A (fr)
NO (1) NO865028L (fr)
NZ (1) NZ218616A (fr)
PT (1) PT83919B (fr)
ZA (1) ZA869373B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
WO1991015176A1 (fr) * 1990-04-06 1991-10-17 Pharmetrix Corporation Dispositif et procede d'administration amelioree de physostigmine
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US5498417A (en) * 1994-05-12 1996-03-12 Coating Sciences, Inc. Transdermal delivery of appetite suppressant drug
US5543133A (en) * 1995-02-14 1996-08-06 Nanosystems L.L.C. Process of preparing x-ray contrast compositions containing nanoparticles
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
ITPD20020138A1 (it) * 2002-05-24 2003-11-24 Matteo Bevilacqua Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
JP5137286B2 (ja) * 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
JP4924837B2 (ja) * 2005-04-20 2012-04-25 千寿製薬株式会社 経皮吸収製剤
WO2008001204A2 (fr) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Compositions transdermiques de pramipexole présentant des propriétés de perméation améliorées

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2040510C3 (de) * 1970-08-14 1980-03-06 Dr. Karl Thomae Gmbh, 7950 Biberach Oxazole- und Thiazole eckige Klammer auf 5,4-d] azepin- Derivate
BG17786A3 (fr) * 1970-08-14 1973-12-25
DE2836387A1 (de) * 1978-08-19 1980-02-28 Boehringer Sohn Ingelheim Retardform fuer einen blutdrucksenkenden und antanginoes wirkenden stoff
JPS56133381A (en) * 1980-03-25 1981-10-19 Nippon Kayaku Co Ltd Pressure-sensitive adhesive tape or sheet containing nitroglycerin
AU553343B2 (en) * 1981-08-10 1986-07-10 Advance Electrode Kabushikikaisya Absorbent adhesive bandage with medicament release
US4400378A (en) * 1981-11-02 1983-08-23 Karl Thomae Gesellschaft Mit Beschrankter Haftung Pharmaceutical composition for the treatment of glaucoma
DE3204551A1 (de) * 1982-02-10 1983-08-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung einer pharmazeutischen zubereitung in form eines polyacrylat-films
CA1225594A (fr) * 1983-05-20 1987-08-18 Jourge Heller Methode pour l'administration percutanee d'agents actifs
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
DE3428342A1 (de) * 1984-08-01 1986-02-13 Boehringer Ingelheim Vetmedica GmbH, 6507 Ingelheim Futtermittelzusatz zur verbesserung des wachstums bei landwirtschaftlichen nutztieren
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device

Also Published As

Publication number Publication date
IL80950A (en) 1991-05-12
JPS62148422A (ja) 1987-07-02
KR870006054A (ko) 1987-07-09
CA1291039C (fr) 1991-10-22
FI865069A (fi) 1987-06-15
US4826686A (en) 1989-05-02
PT83919A (en) 1987-01-01
EP0227988A3 (fr) 1990-04-11
AU6645086A (en) 1987-06-18
FI865069A0 (fi) 1986-12-12
AU593863B2 (en) 1990-02-22
NZ218616A (en) 1990-02-26
EP0227988A2 (fr) 1987-07-08
DK599986A (da) 1987-06-15
PT83919B (pt) 1989-05-12
NO865028D0 (no) 1986-12-12
DK599986D0 (da) 1986-12-12
ZA869373B (en) 1988-08-31

Similar Documents

Publication Publication Date Title
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO863670D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO864110D0 (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO870866D0 (no) Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat.
NO863251D0 (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO865028L (no) Fremgangsmaate for fremstilling av et terapeutisk system.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO862942D0 (no) Fremgangsmaate for fremstilling av kalsiumfluorsilikat.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO164239C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbapenemderivat.
NO164959C (no) Fremgangsmaate for fremstilling av en proteseanordning.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO873571D0 (no) Fremgangsmaate for fremstilling av et terapeutisk virksomt preparat.
NO864087D0 (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
FI88389B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara embonat av kinolonkarboxylsyror
NO863225L (no) Analogifremgangsmaate for fremstilling av et terapeutisk virksomt benzodioxepan.
NO862493L (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.
FI864790A0 (fi) Foerfarande foer framstaellning av 5-klor- och 5-brom-2-hydroxinikotinsyror.
NO864689D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
NO892859L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylalkylaminer.